Latest News and Press Releases
Want to stay updated on the latest news?
-
New class action for Lucid (LCID) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 7/28/2026
-
New class action for SES AI (SES) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 6/26/2026
-
New class action for Calix (CALX) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 7/27/2026
-
New class action for Immutep (IMMP) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 7/6/2026
-
New class action for Regencell (RGC) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 6/23/2026
-
New class action for GeneDx (WGS) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 8/3/2026
-
Washington, D.C., June 14, 2026 (GLOBE NEWSWIRE) -- A deadline most Americans have never heard of is approaching, and former government advisor Jim Rickards says it could reach all the way into the...
-
THE HAGUE, the Netherlands, June 14, 2026 (GLOBE NEWSWIRE) -- Modat today launched native Passive DNS intelligence in Magnify, its internet intelligence platform, unifying IP, device fingerprint,...
-
Treatment with barzolvolimab resulted in rapid, significant, and durable improvements in angioedema in patients with moderate to severe CSUSeven months after the completion of dosing (Week 76), up to...
-
– Verekitug, administered once every three months, led to clinically meaningful improvements in nasal polyp score (NPS) in approximately 80% of participants – – Majority of verekitug-treated...